To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Personalis by 48,470 shares, the number of shares held decreased 0.67% compared to the previous period and now represents 5.53% of the total position.
      37Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 1,740 shares, the number of shares held decreased 0.67% compared to the previous period and now represents 1.56% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Generate Biomedicines by 3,040 shares, the number of shares held decreased 0.67% compared to the previous period and now represents 0.48% of the total position.
      8Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 11,045 shares, the number of shares held decreased 0.67% compared to the previous period and now represents 9.9% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 32,048 shares, the number of shares held decreased 1.07% compared to the previous period and now represents 2.98% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Natera by 1,585 shares, the number of shares held decreased 0.67% compared to the previous period and now represents 4.22% of the total position.
      8Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in CRISPR Therapeutics AG by 12,635 shares, the number of shares held decreased 0.67% compared to the previous period and now represents 7.69% of the total position.
      9Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 2,765 shares, the number of shares held decreased 0.67% compared to the previous period and now represents 2.05% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 13,285 shares, the number of shares held decreased 0.67% compared to the previous period and now represents 4.73% of the total position.
      92Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 12,655 shares, the number of shares held decreased 0.67% compared to the previous period and now represents 2.24% of the total position.
      1Comment
      Report
      • empty
        No followers yet
       
       
       
       

      Most Discussed